New nasal vaccine for COVID-19 set to begin clinical trial in the U.S.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
EurekAlert!1d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
The adenovirus carries the SARS-CoV-2 protein into the nose ... vaccine and subsequently infected did not pass the virus on to others, breaking the cycle of transmission. “All effective vaccines ...